The vaccine has demonstrated a high efficacy rate after one dose, but the company itself has not suggested any policy changes.
0 subscriptions will be displayed on your profile (edit)
Skip for now
For your security, we need to re-authenticate you.
Click the link we sent to , or click here to sign in.